The Ki-67 proliferation index, frequently utilized to evaluate tumor aggressiveness, may have limited reliability in certain MF subtypes, particularly those that appear to be influenced by alternative immunologic or epigenetic processes [4]. The gene discussed is MKI67; the disease is neoplasm.